CSCI logo

COSCIENS Biopharma Stock Price

Symbol: TSX:CSCIMarket Cap: CA$16.7mCategory: Pharmaceuticals & Biotech

CSCI Share Price Performance

CSCI Community Fair Values

    Recent CSCI News & Updates

    No updates

    COSCIENS Biopharma Inc. Key Details

    US$9.0m

    Revenue

    US$4.8m

    Cost of Revenue

    US$4.3m

    Gross Profit

    US$21.8m

    Other Expenses

    -US$17.6m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -5.58
    Gross Margin
    47.26%
    Net Profit Margin
    -194.50%
    Debt/Equity Ratio
    0%

    COSCIENS Biopharma Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About CSCI

    Founded
    1990
    Employees
    40
    CEO
    Anna Biehn
    WebsiteView website
    www.cosciensbio.com

    COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce inflammation for the healthcare and cosmetic industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as for endocrinology and oncology indications. The company sells its products through its distribution network. It has license agreements with Pharmanovia, MegaPharm Ltd., ER Kim Pharmaceuticals Bulgaria Eood, and NK MEDITECH Ltd, as well as Agriculture Canada and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

    Canadian Market Performance

    • 7 Days: 0.7%
    • 3 Months: 10.9%
    • 1 Year: 17.6%
    • Year to Date: 10.6%
    The Healthcare sector gained 3.8% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading